John W. Bostick

John W. Bostick

Auto-generated profile, based on publicly available information

John W. Bostick

Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL 32608, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Immunity
Verified
Journal Article
Closed access
SLShiyang Li
Shiyang Li
JBJohn W. Bostick
John W. Bostick
JYJian Ye
Jian Ye
JQJu Qiu
Ju Qiu
BZBin Zhang
Bin Zhang
LZLiang Zhou
Liang Zhou

1 November 2017 in Cell Reports
Verified
Journal Article
Open access
JYJian Ye
Jian Ye
JQJu Qiu
Ju Qiu
JBJohn W. Bostick
John W. Bostick
AUAki Ueda
Aki Ueda
HSHilde Schjerven
Hilde Schjerven
LZLiang Zhou
Liang Zhou
The local environment may affect the development and function of tissue-resident T regulatory cells (Tregs), which are crucial for controlling inflammation. Although the aryl hydrocarbon receptor (Ahr), an environmental sensor, is expressed by Tregs, its role in Treg cell development and/or function remains elusive. Here, we generated mouse genetic models to ablate or activate Ahr expression specifically in Tregs. We showed that Ahr was expressed more abundantly by peripherally induced Tregs (pTregs) in the gut and that its expression was independent of microbiota. Ahr was important for Treg gut homing and function. Ahr inhibited pro-inflammatory cytokines produced by Tregs but was dispensable for Treg stability. Furthermore, Ahr-expressing Tregs had enhanced in vivo suppressive activity compared with Tregs lacking Ahr expression in a T cell transfer model of colitis. Our data suggest that Ahr signaling in Tregs may be important for gut immune homeostasis.

1 July 2019 in Cell Reports
Verified
Journal Article
Open access
ZFZheng Fu
Zheng Fu
JYJian Ye
Jian Ye
JDJoseph W. Dean
Joseph W. Dean
JBJohn W. Bostick
John W. Bostick
SWSamuel E. Weinberg
Samuel E. Weinberg
LZLiang Zhou
Liang Zhou
Regulatory T cells (Tregs) are pivotal for immune suppression. Cellular metabolism is important for Treg homeostasis and function. However, the exact role of mitochondrial respiration in Tregs remains elusive. Mitochondrial transcription factor A (Tfam) is essential for mitochondrial respiration and controls mitochondrial DNA replication, transcription, and packaging. Here, we show that genetic ablation of Tfam in Tregs impairs Treg maintenance in non-lymphoid tissues in the steady state and in tumors. Tfam-deficient Tregs have reduced proliferation and Foxp3 expression upon glucose deprivation in vitro. Tfam deficiency preferentially affects gene activation in Tregs through regulation of DNA methylation, with enhanced methylation in the TSDR of the Foxp3 locus. Deletion of Tfam in Tregs affects Treg homing and stability, resulting in tissue inflammation in colitis, but enhances tumor rejection. Thus, our work reveals a critical role of Tfam-mediated mitochondrial respiration in Tregs to regulate inflammation and anti-tumor immunity.

12 October 2015 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
JBJohn W. Bostick
John W. Bostick
LZLiang Zhou
Liang Zhou

24 January 2023 in Movement Disorders
Verified
Journal Article
Open access
JBJoseph C. Boktor
Joseph C. Boktor
GSGil Sharon
Gil Sharon
LMLeo A. Verhagen Metman
Leo A. Verhagen Metman
DHDeborah A. Hall
Deborah A. Hall
PEPhillip A Engen
Phillip A Engen
SMSarkis K. Mazmanian
Sarkis K. Mazmanian
Background: The gut microbiome is altered in several neurologic disorders, including Parkinson's disease (PD).Objectives: The aim is to profile the fecal gut metagenome in PD for alterations in microbial composition, taxon abundance, metabolic pathways, and microbial gene products, and their relationship with disease progression.Methods: Shotgun metagenomic sequencing was conducted on 244 stool donors from two independent cohorts in the United States, including individuals with PD (n = 48, n = 47, respectively), environmental household controls (HC, n = 29, n = 30), and community population controls (PC, n = 41, n = 49). Microbial features consistently altered in PD compared to HC and PC subjects were identified. Data were cross‐referenced to public metagenomic data sets from two previous studies in Germany and China to determine generalizable microbiome features.Results: We find several significantly altered taxa between PD and controls within the two cohorts sequenced in this study. Analysis across global cohorts returns consistent changes only in Intestinimonas butyriciproducens. Pathway enrichment analysis reveals disruptions in microbial carbohydrate and lipid metabolism and increased amino acid and nucleotide metabolism in PD. Global gene‐level signatures indicate an increased response to oxidative stress, decreased cellular growth and microbial motility, and disrupted intercommunity signaling.Conclusions: A metagenomic meta‐analysis of PD shows consistent and novel alterations in functional metabolic potential and microbial gene abundance across four independent studies from three continents. These data reveal that stereotypic changes in the functional potential of the gut microbiome are a consistent feature of PD, highlighting potential diagnostic and therapeutic avenues for future research. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

5 January 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
SLShiyang Li
Shiyang Li
JBJohn W. Bostick
John W. Bostick
LZLiang Zhou
Liang Zhou
With striking similarity to their adaptive T helper cell counterparts, innate lymphoid cells (ILCs) represent an emerging family of cell types that express signature transcription factors, including T-bet+ Eomes+ natural killer cells, T-bet+ Eomes− group 1 ILCs, GATA3+ group 2 ILCs, RORγt+ group 3 ILCs, and newly identified Id3+ regulatory ILC. ILCs are abundantly present in barrier tissues of the host (e.g., the lung, gut, and skin) at the interface of host–environment interactions. Active research has been conducted to elucidate molecular mechanisms underlying the development and function of ILCs. The aryl hydrocarbon receptor (Ahr) is a ligand-dependent transcription factor, best known to mediate the effects of xenobiotic environmental toxins and endogenous microbial and dietary metabolites. Here, we review recent progresses regarding Ahr function in ILCs. We focus on the Ahr-mediated cross talk between ILCs and other immune/non-immune cells in host tissues especially in the gut. We discuss the molecular mechanisms of the action of Ahr expression and activity in regulation of ILCs in immunity and inflammation, and the interaction between Ahr and other pathways/transcription factors in ILC development and function with their implication in disease.